search
Back to results

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

Primary Purpose

Smoking, Lung Cancer

Status
Recruiting
Phase
Early Phase 1
Locations
United States
Study Type
Interventional
Intervention
Best Practice
Nicotine Patch
Quality-of-Life Assessment
Questionnaire Administration
Tobacco Cessation Counseling
Sponsored by
M.D. Anderson Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Smoking focused on measuring current smoker, health care provider, primary care doctor

Eligibility Criteria

55 Years - 77 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • PATIENTS: Primary care patients
  • PATIENTS: Upcoming primary care office visit
  • PATIENTS: Current smoker
  • PATIENTS: 30 plus (+) pack-year smoking history
  • PATIENTS: English-speaking
  • PROVIDERS: Primary health care providers
  • PROVIDERS: Provide care to adults

Exclusion Criteria:

  • PATIENTS: History of lung cancer by self-report

Sites / Locations

  • University of Texas Medical Branch
  • M D Anderson Cancer CenterRecruiting
  • University of Texas Health Science Center at Tyler

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Group I (centralized care strategy)

Group II (usual care)

Arm Description

Participants receive counseling over the phone to help them quit smoking and learn about lung cancer screening over 15-20 minutes for 6-8 sessions over 8 weeks. Participants may also receive nicotine patches.

Participants receive counseling on lung cancer screening and smoking cessation from primary care providers at health care visit.

Outcomes

Primary Outcome Measures

Smoking abstinence Questionnairre
Participants achieving the primary abstinence endpoint at 12 weeks (higher 7-day point prevalence abstinence rates)
Lung Cancer Screening 12 items version
Knowledge of lung cancer screening and benefits of smoking cessation

Secondary Outcome Measures

Number of patients who received smoking cessation counseling and shared decision making over the number of patients consented to participate in the study
Assessment of the reach of the intervention
Acceptability, appropriateness, and feasibility of the intervention measure (Weiner et al).
Assessment of the feasibility of implementing the intervention
Fidelity checklist (11 items)
Assessment of the feasibility of implementing the intervention
EuroQoL-5 dimensions
Standardized measure of health-related quality of life used to generate patient utilities (will report lower decisional conflict, greater decision preparation, greater intention to stop smoking, and be more likely to make an attempt to stop smoking.)
Costs of implementing any smoking cessation plus shared decision making intervention
Costs of personnel, hardware, and delivering materials to participants

Full Information

First Posted
August 19, 2019
Last Updated
June 30, 2023
Sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI), Cancer Prevention Research Institute of Texas
search

1. Study Identification

Unique Protocol Identification Number
NCT04200534
Brief Title
Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)
Official Title
Improving the Quality of Smoking Cessation and Shared Decision Making for Lung Cancer Screening: A Cluster Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 31, 2020 (Actual)
Primary Completion Date
February 29, 2024 (Anticipated)
Study Completion Date
February 29, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI), Cancer Prevention Research Institute of Texas

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This trial studies how well a centralized care strategy works in improving the quality of smoking cessation and shared decision making among patients who smoke and are considering lung cancer screening. The centralized care strategy is a model where smokers eligible for lung cancer screening are referred to a dedicated tobacco treatment program where they receive both the shared decision-making and initiate smoking cessation counseling prior to their visit with a primary care provider. Utilizing the centralized care model may work better in helping people quit smoking and make informed decisions about lung cancer screening compared to usual care.
Detailed Description
PRIMARY OBJECTIVE: I. Test the effectiveness of usual care (primary care providers with training in guideline-based smoking cessation and shared decision making) versus (vs.) centralized care (smoking cessation and shared decision making delivered remotely by trained counselors) on smoking abstinence and the quality of patients' decisions about lung cancer screening. SECONDARY OBJECTIVES: I. Evaluate the reach, acceptability, feasibility, and fidelity of the two smoking cessation and shared decision-making implementation models in meeting the requirements from Centers for Medicare & Medicaid Services (CMS) for the lung cancer screening patient counseling and shared decision making visit. II. Conduct budget impact and cost-effectiveness analyses of the two implementation models for the smoking cessation and shared decision making to inform adoption of the intervention beyond the current study. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP I (CENTRALIZED CARE): Participants receive counseling over the phone to help them quit smoking and learn about lung cancer screening over 15-20 minutes for 6-8 sessions over 8 weeks. Participants may also receive nicotine patches. GROUP II (USUAL CARE): Participants receive counseling on lung cancer screening and smoking cessation from primary care providers at health care visit. After completion of study, participants are followed up at 1, 8, and 12 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Smoking, Lung Cancer
Keywords
current smoker, health care provider, primary care doctor

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
520 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group I (centralized care strategy)
Arm Type
Experimental
Arm Description
Participants receive counseling over the phone to help them quit smoking and learn about lung cancer screening over 15-20 minutes for 6-8 sessions over 8 weeks. Participants may also receive nicotine patches.
Arm Title
Group II (usual care)
Arm Type
Active Comparator
Arm Description
Participants receive counseling on lung cancer screening and smoking cessation from primary care providers at health care visit.
Intervention Type
Other
Intervention Name(s)
Best Practice
Other Intervention Name(s)
standard of care, standard therapy
Intervention Description
Receive usual care counseling
Intervention Type
Drug
Intervention Name(s)
Nicotine Patch
Other Intervention Name(s)
NicoDerm CQ, Nicotine Skin Patch, Nicotine Transdermal Patch
Intervention Description
Given nicotine patches
Intervention Type
Other
Intervention Name(s)
Quality-of-Life Assessment
Other Intervention Name(s)
Quality of Life Assessment
Intervention Description
Ancillary studies
Intervention Type
Other
Intervention Name(s)
Questionnaire Administration
Intervention Description
Ancillary studies
Intervention Type
Other
Intervention Name(s)
Tobacco Cessation Counseling
Intervention Description
Receive counseling over the phone
Primary Outcome Measure Information:
Title
Smoking abstinence Questionnairre
Description
Participants achieving the primary abstinence endpoint at 12 weeks (higher 7-day point prevalence abstinence rates)
Time Frame
Up to 12 weeks
Title
Lung Cancer Screening 12 items version
Description
Knowledge of lung cancer screening and benefits of smoking cessation
Time Frame
Up to 12 weeks
Secondary Outcome Measure Information:
Title
Number of patients who received smoking cessation counseling and shared decision making over the number of patients consented to participate in the study
Description
Assessment of the reach of the intervention
Time Frame
Up to 12 weeks
Title
Acceptability, appropriateness, and feasibility of the intervention measure (Weiner et al).
Description
Assessment of the feasibility of implementing the intervention
Time Frame
Up to 12 weeks
Title
Fidelity checklist (11 items)
Description
Assessment of the feasibility of implementing the intervention
Time Frame
Up to 12 weeks
Title
EuroQoL-5 dimensions
Description
Standardized measure of health-related quality of life used to generate patient utilities (will report lower decisional conflict, greater decision preparation, greater intention to stop smoking, and be more likely to make an attempt to stop smoking.)
Time Frame
Up to 12 weeks
Title
Costs of implementing any smoking cessation plus shared decision making intervention
Description
Costs of personnel, hardware, and delivering materials to participants
Time Frame
Up to 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
55 Years
Maximum Age & Unit of Time
77 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: PATIENTS: Primary care patients PATIENTS: Upcoming primary care office visit PATIENTS: Current smoker PATIENTS: 30 plus (+) pack-year smoking history PATIENTS: English-speaking PROVIDERS: Primary health care providers PROVIDERS: Provide care to adults Exclusion Criteria: PATIENTS: History of lung cancer by self-report
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Robert J. Volk
Phone
713-563-0020
Email
volk@mdanderson.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert J Volk
Organizational Affiliation
M.D. Anderson Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Texas Medical Branch
City
Galveston
State/Province
Texas
ZIP/Postal Code
77555-0565
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert J. Volk
Phone
713-563-0020
First Name & Middle Initial & Last Name & Degree
Robert J. Volk
Facility Name
M D Anderson Cancer Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert J. Volk
Phone
713-563-0020
First Name & Middle Initial & Last Name & Degree
Robert J. Volk
Facility Name
University of Texas Health Science Center at Tyler
City
Tyler
State/Province
Texas
ZIP/Postal Code
75708
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert J. Volk
Phone
713-563-0020
First Name & Middle Initial & Last Name & Degree
Robert J. Volk

12. IPD Sharing Statement

Links:
URL
http://www.mdanderson.org
Description
University of Texas MD Anderson Cancer Center Website

Learn more about this trial

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

We'll reach out to this number within 24 hrs